Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0001193125-25-321148

Options or other derivatives

  • Chief Operating Officer acquired 76,027 shares (grant or award)
  • Chief Operating Officer returned 76,027 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Yonehiro Grant · Chief Operating Officer

Table II: Derivative

24 lines
Date Transaction Shares Owned after D/I
2025-12-12 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +3,214 3,214 D
2025-12-12 Returned to the company : show line 2 in the form Employee Stock Option (Right to Buy) −3,214 0 D
2025-12-12 Grant or award : show line 3 in the form Employee Stock Option (Right to Buy) +660 660 D
2025-12-12 Returned to the company : show line 4 in the form Employee Stock Option (Right to Buy) −660 0 D
2025-12-12 Grant or award : show line 5 in the form Employee Stock Option (Right to Buy) +822 822 D
2025-12-12 Returned to the company : show line 6 in the form Employee Stock Option (Right to Buy) −822 0 D
2025-12-12 Grant or award : show line 7 in the form Employee Stock Option (Right to Buy) +1,653 1,653 D
2025-12-12 Returned to the company : show line 8 in the form Employee Stock Option (Right to Buy) −1,653 0 D
Loading xslF345X05/ownership.xml…